ANTIGENICS, INC.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 89.87B | ||||||
| 37.57B | ||||||
| 32.75B | ||||||
| 26.47B | ||||||
| 14.25B |
